Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral minoxidil added to methotrexate for lichen planopilaris
IRCT20220528055005N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of minoxidil and methotrexate in lichen planopilaris (LPP) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Lichen planopilaris disease activity index change, Standard photographic assessment and 1 more. Started Jun 2022; status: completed.
02
Drugs
minoxidilmethotrexate
03
Conditions
lichen planopilaris (LPP)
Beyond the preview
Go deeper on IRCT20220528055005N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220528055005N1.